Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Rapid Dose Therapeutics Corp C.DOSE

Alternate Symbol(s):  RDTCF

Cannabis
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. The Company provides disruptive drug delivery technologies designed to improve patient outcomes. The Company’s flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into... see more

Recent & Breaking News (CSE:DOSE)

IIROC Trade Resumption - DOSE

Canada NewsWire November 19, 2020

CSE Bulletin: Suspensions

Newsfile August 20, 2020

Rapid Dose Therapeutics Announces Cease Trade Order Due to Delay in Annual Filings Under COVID-19 Duress

GlobeNewswire August 20, 2020

IIROC Trading Halt - DOSE

Canada NewsWire August 20, 2020

Rapid Dose Therapeutics Announces a New Board Member

GlobeNewswire August 13, 2020

Rapid Dose Therapeutics Announces Credit Facility Financing

GlobeNewswire August 11, 2020

Rapid Dose Therapeutics Announces Delay in Quarterly Filings Under COVID-19 Duress

GlobeNewswire July 31, 2020

Rapid Dose Therapeutics and McMaster University Initiate QuickStrip(TM) COVID-19 Vaccine Research With Immediate Impact

GlobeNewswire July 21, 2020

Rapid Dose Therapeutics Announces Delay in Annual Filings Under COVID-19 Duress

GlobeNewswire June 26, 2020

Rapid Dose Therapeutics Files a Patent to Synthesize THC From CBD Using a Selective Delta 8 or Delta 9 Conversion Process

GlobeNewswire June 19, 2020

RAPID DOSE THERAPEUTICS Signs agreement with Leede Jones Gable to provide Financial Advisory Services and Announces Change to its Board of Directors

GlobeNewswire May 29, 2020

RAPID DOSE THERAPEUTICS DONATES QUICKSTRIP(TM) VITAMIN B12 NUTRACEUTICAL PRODUCT TO COMMUNITY

GlobeNewswire April 2, 2020

RAPID DOSE THERAPEUTICS ANNOUNCES SHIPMENT OF QUICKSTRIP(TM) NUTRACEUTICAL PRODUCTS

GlobeNewswire March 31, 2020

IIROC Trade Resumption - DOSE

Canada NewsWire March 23, 2020

IIROC Trading Halt - DOSE

Canada NewsWire March 23, 2020

Rapid Dose Therapeutics Announces Investment Agreement With Institutional Investor

GlobeNewswire March 5, 2020

Rapid Dose Therapeutics Announces Nutraceutical Reseller Agreement for Canada, United States and India

GlobeNewswire February 27, 2020

Rapid Dose Therapeutics Announces Issuance of CRA Cannabis Licence and Board and Management Changes

GlobeNewswire February 21, 2020

Rapid Dose Therapeutics Receives Funding for Scale-Up Manufacturing and Commercialization of Quickstrip(TM) Product

GlobeNewswire February 4, 2020

Rapid Dose Therapeutics and McMaster University Awarded NSERC Research and Development Grant to Develop Oral Dissolvable Film for Enhanced Drug Delivery

GlobeNewswire January 23, 2020